LAUREL O'BARTO: Open Payments
NPI 1982398145 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $147 · 2025 $484
Food & beverage: $484
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Medtronic, Inc. | 1 | $111 |
| PFIZER INC. | 3 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Novo Nordisk Inc | 1 | $33 |
| Kestra Medical Technology Services, Inc. | 1 | $31 |
| Boston Scientific Corporation | 1 | $15 |
Products named: CAMZYOS, COREVALVE EVOLUT R, Kerendia, VYNDAQEL, JARDIANCE, LEQVIO, Wegovy, Assure WCD.
Industry payments across VA — which companies pay providers there.
